<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Immunosuppressive regimens, which include antithymocyte globulin (ATG), are widely used for the treatment of severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) </plain></SENT>
<SENT sid="1" pm="."><plain>However, <z:hpo ids='HP_0001662'>bradycardia</z:hpo> has been reported only as a rare side effect of ATG therapy in the manufacturer's product information and, in rare cases, in the adult literature </plain></SENT>
<SENT sid="2" pm="."><plain>We present an adolescent with SAA and preexisting <z:hpo ids='HP_0001662'>bradycardia</z:hpo> who underwent immunosuppression therapy with ATG, <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi>, and tacrolimus and developed profound <z:hpo ids='HP_0001688'>sinus bradycardia</z:hpo> with successive doses of ATG </plain></SENT>
</text></document>